expert reaction to trial of new amylin-based weight-loss drug petrelintide, noting fewer side effects than GLP-1-based drugs
Scientist comment on the trial of a new amylin-based weight-loss drug petrelintide, noting fewer side effects than GLP-1-based drugs, as … read more